Starting Strong at First Relapse in Multiple Myeloma: Insights to Guide Treatment Selection in Lenalidomide-Refractory Patients
PeerVoice Clinical Pharmacology Video
English - August 29, 2022 23:00 - 16 minutesScience medical education peervoice clinical pharmacology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: New Biomarkers, New Targets in Advanced NSCLC
Starting Strong at First Relapse in Multiple Myeloma: Insights to Guide Treatment Selection in Lenalidomide-Refractory Patients